Infectious Disease Diagnostics Market (By Product: Assays & Reagents, Instruments, Software; By Disease Type: Hepatitis, Human Immunodeficiency Virus, Influenza, Others; By Technology: Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, Next-generation Sequencing, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2034
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Infectious Disease Diagnostics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Infectious Disease Diagnostics Market, by Product, 2024-2034
8.1.1 Assays & Reagents
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Instruments
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Software
8.1.3.1. Market Revenue and Forecast (2021-2034)
9.1. Infectious Disease Diagnostics Market, by Disease Type, 2024-2034
9.1.1. Hepatitis
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Human Immunodeficiency Virus
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Influenza
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2021-2034)
10.1. Infectious Disease Diagnostics Market, by Technology, 2024-2034
10.1.1. Immunodiagnostics
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Clinical Microbiology
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Polymerase Chain Reaction
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Next-generation Sequencing
10.1.4.1. Market Revenue and Forecast (2021-2034)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2021-2034)
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2021-2034)
11.1.2. Market Revenue and Forecast, by Disease Type (2021-2034)
11.1.3. Market Revenue and Forecast, by Technology (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.1.4.2. Market Revenue and Forecast, by Disease Type (2021-2034)
11.1.4.3. Market Revenue and Forecast, by Technology (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.1.5.2. Market Revenue and Forecast, by Disease Type (2021-2034)
11.1.5.3. Market Revenue and Forecast, by Technology (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2021-2034)
11.2.2. Market Revenue and Forecast, by Disease Type (2021-2034)
11.2.3. Market Revenue and Forecast, by Technology (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.2.4.2. Market Revenue and Forecast, by Disease Type (2021-2034)
11.2.4.3. Market Revenue and Forecast, by Technology (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.2.5.2. Market Revenue and Forecast, by Disease Type (2021-2034)
11.2.5.3. Market Revenue and Forecast, by Technology (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product (2021-2034)
11.2.6.2. Market Revenue and Forecast, by Disease Type (2021-2034)
11.2.6.3. Market Revenue and Forecast, by Technology (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product (2021-2034)
11.2.7.2. Market Revenue and Forecast, by Disease Type (2021-2034)
11.2.7.3. Market Revenue and Forecast, by Technology (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2021-2034)
11.3.2. Market Revenue and Forecast, by Disease Type (2021-2034)
11.3.3. Market Revenue and Forecast, by Technology (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.3.4.2. Market Revenue and Forecast, by Disease Type (2021-2034)
11.3.4.3. Market Revenue and Forecast, by Technology (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.3.5.2. Market Revenue and Forecast, by Disease Type (2021-2034)
11.3.5.3. Market Revenue and Forecast, by Technology (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product (2021-2034)
11.3.6.2. Market Revenue and Forecast, by Disease Type (2021-2034)
11.3.6.3. Market Revenue and Forecast, by Technology (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product (2021-2034)
11.3.7.2. Market Revenue and Forecast, by Disease Type (2021-2034)
11.3.7.3. Market Revenue and Forecast, by Technology (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.4.2. Market Revenue and Forecast, by Disease Type (2021-2034)
11.4.3. Market Revenue and Forecast, by Technology (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.4.4.2. Market Revenue and Forecast, by Disease Type (2021-2034)
11.4.4.3. Market Revenue and Forecast, by Technology (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.4.5.2. Market Revenue and Forecast, by Disease Type (2021-2034)
11.4.5.3. Market Revenue and Forecast, by Technology (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product (2021-2034)
11.4.6.2. Market Revenue and Forecast, by Disease Type (2021-2034)
11.4.6.3. Market Revenue and Forecast, by Technology (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product (2021-2034)
11.4.7.2. Market Revenue and Forecast, by Disease Type (2021-2034)
11.4.7.3. Market Revenue and Forecast, by Technology (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.5.2. Market Revenue and Forecast, by Disease Type (2021-2034)
11.5.3. Market Revenue and Forecast, by Technology (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.5.4.2. Market Revenue and Forecast, by Disease Type (2021-2034)
11.5.4.3. Market Revenue and Forecast, by Technology (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.5.5.2. Market Revenue and Forecast, by Disease Type (2021-2034)
11.5.5.3. Market Revenue and Forecast, by Technology (2021-2034)
12.1. Abbott Laboratories
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Becton Dickinson and Company
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. bioMerieus SA
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Bio-Rad Laboratories
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Danaher Corporation
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. F Hoffman-La Roche
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Hologic Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Luminex Corporation
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Qiagen Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Thermo Fisher Scientific Inc.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample